GlassScriptPhysician profile
Ahmed E Doomi
NPI 1518617448
$18,934.27
in general payments reported to CMS, 2019-2025
8 companies · $1,090 in 2025
The $1,090 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15K · 2023: $138 · 2024: $2,706 · 2025: $1,090.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,929 · Food and Beverage: $1,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,929.33 |
| Food and Beverage | $1,004.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,649.15 | 2023-2025 | Proclaim |
| Medtronic, INC. | $1,214.86 | 2024 | Stealthstation S8 Platform, Mazor X System, Intellis Adaptivestim |
| Mid-Atlantic Surgical Systems, LLC | $643.78 | 2025 | |
| Si-Bone, INC. | $189.70 | 2025 | |
| Kuros Biosciences USA, INC | $97.87 | 2025 | Magnetos |
| Globus Medical, INC. | $60.12 | 2025 | Elsa |
| Providence Medical Technology, INC. | $45.40 | 2024 | |
| Integra Lifesciences Corporation | $33.39 | 2024 | Codman Hakim, Cusa Clarity, Codman Certas |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Doomi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.